Jiangsu Hansoh ADC HS-20093 holds potential to set new standard in SCLC second-line treatment in… EP News Bureau Nov 22, 2024 HS-20093: A breakthrough ADC poised to redefine second-line SCLC care in China, strengthening Jiangsu Hansoh's oncology leadership…
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer EP News Bureau Sep 1, 2020 Imfinzi, in combination with etoposide and either carboplatin or cisplatin, is also approved in the US, Japan and several other…
Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India EP News Bureau Nov 21, 2019 Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given…
